Advances in neuropharmacology (Record no. 61)

MARC details
000 -LEADER
fixed length control field 02937nam a2200229 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 24cm
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781774634714
100 ## - MAIN ENTRY--AUTHOR
Author Uddin Md. Sahab
245 00 - TITLE STATEMENT
Title Advances in neuropharmacology
Remainder of title drugs and therapeutics
Statement of responsibility, etc edited by Md. Sahab Uddin, Mamunur Rashid.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication Burlington
Name of publisher Apple Academic Press
Date of publication 2020
300 ## - COLLATION
Pagination xxii, 621pages
Other physical details ills..
520 ## - SUMMARY, ETC.
Summary, etc "This new volume, Advances in Neuropharmacology: Drugs and Therapeutics, provides a comprehensive overview of the drugs that act on the central and peripheral nervous systems. It thoroughly describes the diseases that are associated with the nervous system and drugs used their treatment while also looking at the current status of these drugs and their future potential and challenges. This book is divided into three sections that describe the nervous system associated diseases and their treatment as well as current status and future opportunities and challenges. Section 1 focuses on the drugs that affect the functions of the autonomic nervous system to produce therapeutic effects. These drugs may act presynaptically by manipulating the genesis, storage, and secretion, and by blocking the action of neurotransmitters. Some drugs may trigger or impede postsynaptic receptors. Section 2 focuses on drugs that affect the central nervous system, including antianxiety drugs, sedative and hypnotic drugs, antidepressant drugs, antipsychotic drugs, antiepileptic drugs, and many more. It covers the pharmacological management of various diseases, including Alzheimer's, Parkinson's, Huntington's disease, and others. Section 3 offers explanations of neurochemical interactions with the aim to develop drugs that have beneficial effects on neurochemical imbalances. This section demonstrates models to assess the transport of drugs across the blood-brain barrier and nanomedicine to treat brain disorders. This rich compilation provides thorough and extensive research updates on the important advances in neuropharmacological drugs and drug therapy from experienced and eminent academicians, researchers, and scientists from throughout the world. It will be rich resource for professionals, academicians, students, researchers, scientists, and industry professionals around the world in the biomedical, health, and life science fields. Key features: Presents recent advances in neuropharmacology, covering the drugs that act on the central and peripheral nervous systems Provides extensive explanations of various emerging research in this field Explores the intricacy of neurological disorders Looks at existing and forthcoming therapeutic drug strategies"--
650 12 - TRACINGS
Main Subject Central Nervous System Agents
650 22 - TRACINGS
Main Subject Autonomic Nervous System
Subdivision (2nd) drug effects
650 22 - TRACINGS
Main Subject Brain Diseases
Subdivision (2nd) drug therapy
650 22 - TRACINGS
Main Subject Neuropharmacology
700 1# - ADDITIONAL AUTHOR
Additional Author Sahab Uddin, Md.,
700 1# - ADDITIONAL AUTHOR
Additional Author Rashid, Mamunur
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Item type Books
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM315.N487 2021
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7/8
Holdings
Source of classification or shelving scheme Not for loan Permanent location Current location Date acquired Accession No. Full call number Barcode. Koha item type
Library of Congress Classification   FUHSI LIBRARY FUHSI LIBRARY 2023-06-15 0000209 RM315.N487 2021 0000209 Books
Library of Congress Classification   FUHSI LIBRARY FUHSI LIBRARY 2023-06-15 0000210 RM315.N487 2021 0000210 Books